Fundz

Fundz Deep Dive

Everything you need to win Janet Hammond — in one platform.

Who to reach, what to say, and why now on Janet Hammond — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Janet Hammond — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Enterprise Therapeutics Appoints Dr Renu Gupta As CMO and Dr Janet Hammond As Non Executive Director

PRIVATEJun 17, 2024almost 2 years ago

Position

Director

Company

Enterprise Therapeutics Ltd

Janet Hammond
BrightonBiotechnologyHealth CareTherapeuticsBiopharma

Description

Enterprise Therapeutics announced the appointment of Dr Renu Gupta as CMO and Dr Janet Hammond as a Non-Executive Director. Dr Gupta brings over 20 years of experience in the biopharmaceutical industry, while Dr Hammond has over 20 years’ experience in the pharmaceutical industry, overseeing the development and successful approval of several drugs.

Company Information

Company

Enterprise Therapeutics Ltd

Location

Brighton, England, United Kingdom

About

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. The company benefits from a close working relationship with the School of Life Sciences at the University of Sussex.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Enterprise Therapeutics Ltd's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.